1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
695FBEAD5524A8C0100258BD5004951C8
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/95FBEAD5524A8C0100258BD5004951C8?OpenDocument
18
19OpenDocument
2018.97.14.83
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Document Excerpt: Best Practices in Improving Medical Affairs Booth Impact: Information Availability and Poster/Investigator Receptions

DB Image

ID: MD-935


Features:

10 Info Graphics

11 Data Graphics

240+ Metrics

11 Narratives


Pages/Slides: 4


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5835 “Best Practices in Improving Medical Affairs Booth Impact: Information Availability and Poster/Investigator Receptions”.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care


Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.